PT Kalbe Farma Tbk (ISX:KLBF) Cyclically Adjusted FCF per Share: Rp40.74 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:KLBF PT Kalbe Farma Tbk ISX:KLBF
77 GF Score
Price Rp725.00
GF Value Rp1,764.67
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is PT Kalbe Farma Tbk Cyclically Adjusted FCF per Share?

PT Kalbe Farma Tbk ISX:KLBF 77 Cyclically Adjusted FCF per Share is Rp40.74 as of Mar. 2026. GuruFocus rates ISX:KLBF with a GF Score™ of 77/100 and a GF Value™ of Rp1,764.67 (Significantly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

PT Kalbe Farma Tbk's adjusted free cash flow per share for the three months ended in Mar. 2026 was Rp1.976. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is Rp40.74 for the trailing ten years ended in Mar. 2026.

During the past 12 months, PT Kalbe Farma Tbk's average Cyclically Adjusted FCF Growth Rate was 8.20% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 10.90% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 8.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of PT Kalbe Farma Tbk was 10.90% per year. The lowest was 7.30% per year. And the median was 9.05% per year.

As of today (2026-08-03), PT Kalbe Farma Tbk's current stock price is Rp725.00. PT Kalbe Farma Tbk's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was Rp40.74. PT Kalbe Farma Tbk's Cyclically Adjusted Price-to-FCF of today is 17.80.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of PT Kalbe Farma Tbk was 79.97. The lowest was 17.06. And the median was 53.98.


PT Kalbe Farma Tbk  (ISX:KLBF) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

PT Kalbe Farma Tbk's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=725.00/40.74
=17.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of PT Kalbe Farma Tbk was 79.97. The lowest was 17.06. And the median was 53.98.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


PT Kalbe Farma Tbk Cyclically Adjusted FCF per Share Related Terms


PT Kalbe Farma Tbk Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for PT Kalbe Farma Tbk's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Kalbe Farma Tbk Cyclically Adjusted FCF per Share Chart

PT Kalbe Farma Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.94 29.51 34.25 37.96 40.24

PT Kalbe Farma Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.65 39.49 39.73 40.24 40.74

ISX:KLBF vs LLY, JNJ, ABBV: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - General subindustry, PT Kalbe Farma Tbk's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Kalbe Farma Tbk Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Kalbe Farma Tbk's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where PT Kalbe Farma Tbk's Cyclically Adjusted Price-to-FCF falls into.


ISX:KLBF
77GF Score
PT Kalbe Farma Tbk ISX:KLBF
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Kalbe Farma Tbk Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PT Kalbe Farma Tbk's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.976/136.5387*136.5387
=1.976

Current CPI (Mar. 2026) = 136.5387.

PT Kalbe Farma Tbk Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 3.632 103.212 4.805
201609 11.510 104.142 15.090
201612 6.890 105.222 8.941
201703 2.876 106.476 3.688
201706 3.363 107.722 4.263
201709 6.029 108.020 7.621
201712 4.218 109.017 5.283
201803 4.348 110.097 5.392
201806 0.707 111.085 0.869
201809 13.449 111.135 16.523
201812 11.315 112.430 13.741
201903 -2.549 112.829 -3.085
201906 1.281 114.730 1.524
201909 3.823 114.905 4.543
201912 8.539 115.486 10.096
202003 7.432 116.252 8.729
202006 11.301 116.630 13.230
202009 16.372 116.397 19.205
202012 31.100 117.318 36.195
202103 0.318 117.840 0.368
202106 2.386 118.184 2.757
202109 29.062 118.262 33.553
202112 7.171 119.516 8.192
202203 3.810 120.948 4.301
202206 -4.212 123.322 -4.663
202209 -0.520 125.298 -0.567
202212 9.534 126.098 10.323
202303 0.148 126.953 0.159
202306 1.079 127.663 1.154
202309 14.121 128.151 15.045
202312 21.947 129.395 23.159
202403 18.464 130.607 19.303
202406 17.324 130.792 18.085
202409 19.115 130.361 20.021
202412 21.575 131.432 22.413
202503 4.069 131.948 4.211
202506 17.777 133.241 18.217
202509 13.872 133.819 14.154
202512 18.380 135.271 18.552
202603 1.976 136.539 1.976

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of Rp40.74 mean?
PT Kalbe Farma Tbk (ISX:KLBF) has a Cyclically Adjusted FCF per Share of Rp40.74 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on PT Kalbe Farma Tbk and its competitors.
Is PT Kalbe Farma Tbk's Cyclically Adjusted FCF per Share too high?
PT Kalbe Farma Tbk's current Cyclically Adjusted FCF per Share is Rp40.74. Overall, PT Kalbe Farma Tbk has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Kalbe Farma Tbk's Cyclically Adjusted FCF per Share compare to LLY and JNJ?
PT Kalbe Farma Tbk's Cyclically Adjusted FCF per Share of Rp40.74 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on PT Kalbe Farma Tbk and its competitors. PT Kalbe Farma Tbk's current Cyclically Adjusted FCF per Share is Rp40.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Kalbe Farma Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Kalbe Farma Tbk (ISX:KLBF) is currently considered Significantly Undervalued. The stock's GF Value™ is Rp1,764.67, compared to a current price of Rp725.00 — trading 58.9% below its estimated fair value. The current Cyclically Adjusted FCF per Share is Rp40.74. PT Kalbe Farma Tbk's overall GF Score™ is 77/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For PT Kalbe Farma Tbk (ISX:KLBF), the current Cyclically Adjusted FCF per Share is Rp40.74 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Kalbe Farma Tbk (ISX:KLBF) Overvalued in 2026?

Based on GuruFocus' analysis, PT Kalbe Farma Tbk stock appears to be undervalued. The current stock price of Rp725.00 is trading 58.9% below its estimated GF Value™ of Rp1,764.67. GuruFocus considers PT Kalbe Farma Tbk to be Significantly Undervalued.

Key valuation signals for ISX:KLBF:

  • Cyclically Adjusted FCF per Share: Rp40.74
  • GF Value™: Rp1,764.67 vs. price of Rp725.00 (58.9% below fair value)
  • GF Score™: 77/100 with 3 warning signs

No single metric tells the full story. See the ISX:KLBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Kalbe Farma Tbk Business Description

Address Jalan Let. Jend. Suprapto Kav. 4, Gedung KALBE, Cempaka Putih, P.O. Box 3105, Jakarta, IDN, 10510
PT Kalbe Farma Tbk is engaged in the development, manufacturing, and trading of pharmaceutical products, including human medicines and consumer health products. The company operates four segments: prescription pharmaceuticals, consumer health, Nutritionals, and distribution and logistics. The majority of the company's revenue is derived from the distribution and logistics segments. Its Product and Services are Prescription /Ethicals, Consumer Health, Nutritionals, Distribution & Logistics, Health Services, Medical Devices, and Others.
77GF Score

Get the complete analysis for ISX:KLBF

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp725.00
Price
Rp1,764.67
GF Value